The financials
AptarGroup, Inc. by the numbers
AptarGroup, Inc. (ATR) reported revenue of $1.03B in Q2 2026 (quarter ended June 30, 2026), up 6.3% from the same quarter a year earlier. That came with a gross margin of 36% and net income of $88M (8.6% of revenue). For the full year FY2025, revenue was $3.78B (+5.4% year on year) and net income $392M. Its largest segment in 2026-Q2 was Pharma at $231M, 44% of the disclosed total, just ahead of Beauty at 42%.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $1.03B | $966M | +6.3% |
| Gross profit | $366M | $367M | −0.4% |
| Operating income | $127M | $144M | −12% |
| Net income | $88M | $112M | −21% |
| Diluted EPS | $1.36 | $1.67 | −19% |
| Operating | Revenue | Share |
|---|---|---|
| Pharma | $231M | 44% |
| Beauty | $221M | 42% |
| Closures | $69M | 13% |
Business Segments
Revenue split by operating segment, from SEC XBRL filings.
Latest period: Q2 2026Total $521.0M (+2.0%)
Closures grew +17% year on yearBeauty +7.8% year on year
Segment Latestquarter on quarteryear on year
- Pharma$230.7M$230.7MQoQ +1.8%year on year +8.9%+1.8%+8.9%
- Beauty$221.2M$221.2MQoQ -0.76%year on year +7.8%-0.76%+7.8%
- Closures$69.1M$69.1MQoQ +13%year on year +17%+13%+17%
- Aptar Beauty--QoQ -year on year ---
- Aptar Closures--QoQ -year on year ---
- Aptar Pharma--QoQ -year on year ---
Medical Instruments & Supplies
Ranks #21 of 27 by Smart Score